A Study to Assess the Relative Bioavailability of Three Formulations and Food Effect on GSK1322322 in Healthy Subjects

NCT01648179 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

24

Enrollment

INDUSTRY

Sponsor class

Conditions

Infections, Bacterial

Interventions

DRUG: GSK1322322 (mesylate salt) Powder for Injection
DRUG: GSK1322322 (freebase) tablets
DRUG: GSK1322322 (mesylate salt) Powder for Oral Solution
DRUG: GSK1322322 (freebase) tablets FED

Sponsor

GlaxoSmithKline